The reduction in price target by a significant margin suggests that Barclays has revised its expectations for EPAM's future performance downwards. This adjustment is likely due to factors that could impact EPAM's market value or financial health, leading to a potential short-term negative impact on the stock price. The Equal-Weight rating indicates that the stock is expected to perform in line with the market or sector, but the lowered price target could influence investor sentiment negatively.